Essential Oils as Novel Anthelmintic Drug Candidates

Molecules. 2022 Nov 29;27(23):8327. doi: 10.3390/molecules27238327.

Abstract

Helminths, with an estimated 1.5 billion annual global infections, are one of the major health challenges worldwide. The current strategy of the World Health Organization to prevent helminth infection includes increasing hygienic awareness, providing better sanitation and preventative anthelmintic drug therapy in vulnerable populations. Nowadays, anthelmintic drugs are used heavily in livestock, both in case of infection and as a preventative measure. However, this has led to the development of resistance against several of the most common drugs, such as levamisole, ivermectin and thiabendazole. As many as 70% of the livestock in developed countries now has helminths that are drug resistant, and multiple resistance is common. Because of this, novel anthelmintics are urgently needed to help combat large-scale production losses. Prior to this review, no comprehensive review of the anthelmintic effects of essential oils and their components existed. Multiple review articles have been published on the uses of a single plant and its extracts that only briefly touch upon their anthelmintic activity. This review aims to provide a detailed overview of essential oils and their components as anthelmintic treatment against a wider variety of helminths.

Keywords: anthelmintic; essential oil; gastro-intestinal nematodes; human helminths; synergy; toxicity.

Publication types

  • Review

MeSH terms

  • Animals
  • Anthelmintics* / pharmacology
  • Anthelmintics* / therapeutic use
  • Drug Resistance
  • Helminthiasis* / drug therapy
  • Helminths*
  • Humans
  • Levamisole / pharmacology
  • Oils, Volatile* / pharmacology
  • Oils, Volatile* / therapeutic use

Substances

  • Oils, Volatile
  • Anthelmintics
  • Levamisole

Grants and funding

Sujogya Kumar Panda received funds in the form of Multi-Stakeholder Grants for Young Researchers (KU Leuven; financial project code: ZKD7946).